- CA$105.70m
- CA$137.32m
- CA$6.79m
- 26
- 50
- 64
- 44
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 29.3 | 18 | 18.4 | 8.65 | 6.79 |
Cost of Revenue | |||||
Gross Profit | 1.81 | 8.87 | 8.37 | 5.58 | 4.83 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 72.2 | 173 | 76 | 31.8 | 20.3 |
Operating Profit | -42.9 | -155 | -57.6 | -23.1 | -13.5 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -2.51 | -77.8 | -94 | 34.6 | -40.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -19.4 | -89.7 | -97.1 | 29 | -39.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -15.3 | -65.4 | -93 | 17.1 | -38.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -22.7 | -71.2 | -96.7 | 12.8 | -37.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.163 | -0.669 | -1.05 | 0.301 | -0.42 |